A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Study sponsor: BioAtla, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-09-22Actual
Enrollment · participants42Actual
Source updated2025-09-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.